enGene Therapeutics Inc.
Filer record as of 2026-09-08. Source: SEC EDGAR
- Business address
- 4868 RUE LEVY, SUITE 220, SAINT-LAURENT
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Cik
- 1980845
- Edgar url
- https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1980845
- Entity type
- operating
- Exchanges
- Nasdaq,Nasdaq
- Fiscal year end
- 1031
- Former names
- enGene Holdings Inc.
- Name
- enGene Therapeutics Inc.
- Sic
- 2836
- Sic description
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- Z4
- Tickers
- ENGN,ENGNW
Filings
- enGene Therapeutics Inc. 8-K filed 2026-09-08 2026-09-08, 8-K
- enGene Therapeutics Inc. 10-Q filed 2026-09-08 2026-09-08, 10-Q